Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mark Catherwood

Transformation of MDS/MPN-RS-T to AML: Trisomy 13, Resistant Thrombocytosis and Transient Disease Control With Oral Busulfan Therapy

American Journal of Hematology

Hematology

2017

English

Acute Promyelocytic Leukaemia (APML) With Cryptic PML-RARA Fusion Has a Clinical Course Comparable to Classical APML With T(15;17)(q24.1;q21.2) Translocation

British Journal of Haematology

Hematology

2018

English

Related publications

Lenalidomide Therapy in Patients With Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)

American Journal of Hematology

Hematology

2017

English

Response to Erythropoiesis‐stimulating Agents in Patients With WHO‐defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis (MDS/MPN‐RS‐T)

British Journal of Haematology

Hematology

2020

English

From MDS/AML to iPSC and Back Again

Science Translational Medicine

Medicine

2017

English

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

English

Translocation T(1;3)(p36;p21) and Other Aberrations in a Case of AML Secondary to MDS

Atlas of Genetics and Cytogenetics in Oncology and Haematology

English

Genetic Deletions in AML and MDS

Best Practice and Research in Clinical Haematology

Oncology

Clinical Biochemistry

2010

English

Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS

Bone Marrow Transplantation

Transplantation

Hematology

2016

English

Isolated Trisomy 13 Defines a Homogeneous AML Subgroup With High Frequency of Mutations in Spliceosome Genes and Poor Prognosis

English

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML

Frontiers in Pharmacology

Pharmacology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mark Catherwood

Transformation of MDS/MPN-RS-T to AML: Trisomy 13, Resistant Thrombocytosis and Transient Disease Control With Oral Busulfan Therapy

Acute Promyelocytic Leukaemia (APML) With Cryptic PML-RARA Fusion Has a Clinical Course Comparable to Classical APML With T(15;17)(q24.1;q21.2) Translocation

Related publications

Lenalidomide Therapy in Patients With Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)

Response to Erythropoiesis‐stimulating Agents in Patients With WHO‐defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis (MDS/MPN‐RS‐T)

From MDS/AML to iPSC and Back Again

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Translocation T(1;3)(p36;p21) and Other Aberrations in a Case of AML Secondary to MDS

Genetic Deletions in AML and MDS

Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS

Isolated Trisomy 13 Defines a Homogeneous AML Subgroup With High Frequency of Mutations in Spliceosome Genes and Poor Prognosis

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML